Neurological manifestations of COVID-19

Pharmacology, Toxicology and Pharmaceutical Science

• SARS Coronavirus 100%
• Neurotoxicity 50%
• Coronavirinae 50%
• Dizziness 50%
• Infectious Complication 50%
• Headache 50%
• Receptor 50%
• Angiotensin Converting Enzyme 2 50%
• Ataxia 50%
• Cerebrovascular Disease 50%
• Anosmia 50%
• Ageusia 50%
• Diseases 50%

Neuroscience

• SARS Coronavirus 100%
• Coronavirus 50%
• Neurotoxicity 50%
• Angiotensin Converting Enzyme 2 50%
• Microglia 50%
• Coronavirinae 50%
• Headache 50%
• Cerebrovascular Disease 50%
• Ataxia 50%
• Anosmia 50%
• Receptor 50%

Medicine and Dentistry

• COVID-19 100%
• Neurologic Finding 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 33%
• Receptor 16%
• Headache 16%
• Ataxia 16%
• Infectious Complication 16%
• Cerebrovascular Disease 16%
• Ageusia 16%
• Anosmia 16%
• Angiotensin Converting Enzyme 2 16%
• Epileptic Seizure 16%
• Dizziness 16%
• Coronavirinae 16%
• Microglia 16%
• Neurotoxicity 16%
• Diseases 16%